Immuron
IMRN
4 hedge funds and large institutions have $1.13M invested in Immuron in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.
33% more funds holding
Funds holding: 3 → 4 (+1)
0.04% less ownership
Funds ownership: 1.99% → 1.94% (-0.04%)
13% less capital invested
Capital invested by funds: $1.3M → $1.13M (-$174K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$105 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$22.9K |
IMRN Hedge Fund Activity: Q2 2018 in Review
4 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Immuron (IMRN) for Q2 2018, worth a combined $1.13M — down 13% from $1.3M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new IMRN positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Morgan Stanley, opening a new position worth an estimated $105. The largest seller was UBS Group, cutting an estimated $22.9K.
- 4 institutional investors held Immuron (IMRN) as of Q2 2018, up from 3 in Q1 2018.
- Funds reported $1.13M of Immuron stock for Q2 2018, down 13% quarter-over-quarter.
- 1 fund opened new Immuron positions in Q2 2018 and 0 closed out, a net change of +1 holder.
- The largest Immuron buyer in Q2 2018 was Morgan Stanley, an estimated $105 added.
- The largest Immuron seller in Q2 2018 was UBS Group, an estimated $22.9K sold.
Based on aggregated 13F filings for Q2 2018.